Secondary Logo

Journal Logo

August 1994 - Volume 16 - Issue 2
pp: 77-172

PDF Only



PDF Only



PDF Only



Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session I: Radiochemistry of Antibodies: PDF Only


Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session II: Experimental Studies of Antibody Targeting: PDF Only


Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Sessions III & IV: Clinical Studies of Radioimmunodetection, I–II: PDF Only


Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session V: Radiation Physics and Dosimetry: PDF Only


Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session VI: Experimental Radioimmunotherapy: PDF Only


Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session VII: Pretargeting Methods: PDF Only


Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session VIII: Clinical Radioimmunotherapy, I: PDF Only


131I-LABELED M195 FOR MYELOID LEUKEMIAS

Jurcic, J. G.; Caron, P. C.; Papadopoulos, E. B.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 16(2):161, August 1994.

Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session IX: Clinical Radioimmunotherapy, II: PDF Only


Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session X: Reengineered Antibodies: PDF Only


SINGLE-CHAIN Fv FUSIONS WITH C-TERMINAL CYSTEINE PEPTIDES (sFv'): DIVALENT ANTI-c-ertB-2 (sFv')2 SHOWS IMPROVED SOLUTION BEHAVIOR IN VITRO AND ENHANCED TUMOR LOCALIZATION IN VIVO COMPARED TO MONOVALENT Fab or sFv

Huston, J. S.; McCartney, J. E.; Tai, M. -S.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 16(2):164, August 1994.

Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Poster Session: PDF Only


Show: